General Anesthesia or Combined Spinal-epidural Anesthesia With Ketofol Sedation in Colon Cancer Surgery?
Trial Snapshot
- Phase
- Not Applicable
- Sponsor
- Ankara City Hospital Bilkent
- Enrollment
- 60
- Primary Endpoint
- urinary catheter withdrawal time
Study Overview
Brief Summary
Anesthesia management in colon cancer surgery affects the postoperative mobilization, discharge and oral intake times of the patients. Due to the side effects of opioids, their use is tried to be reduced and therefore regional anesthesia methods are preferred in suitable patients. Especially in the preoperative period, opioid use has a negative effect on the recovery processes, morbidity and mortality of the patients. Epidural analgesia, a central block method, is recommended for postoperative pain control in ERAS protocols. Opioids suppress cellular and humoral immunity. Epidural analgesia reduces both opioid consumption and surgical stress response. It has been shown that epidural analgesia maintains the immune functions of patients and is associated with a decrease in tumor recurrence. It has also been shown to reduce postoperative pain, hypercoagulability and pulmonary complications, increase exercise capacity and accelerate the return of intestinal functions to normal. In line with this information, in this study, it was aimed to investigate the differences in the postoperative period in patients managed with regional anesthesia.
In the study, it was planned to create two groups who underwent open surgery for colon cancer. The first group will be operated under general anesthesia and the second group will be operated under combined spinal-epidural anesthesia with ketofol sedation. An epidural catheter will be inserted in both groups for postoperative pain management. In the study, patients' age, gender, weight, comorbidity, ASA score, amount of local anesthetic used, postoperative VAS scores, mobilization time, time to start oral intake, nasogastric withdrawal time, drain removal time, urinary catheter withdrawal time, hospitalization time and total cost will be evaluated.
Study Design
- Study Type
- Observational
- Observational Model
- Cohort
- Time Perspective
- Prospective
Eligibility Criteria
- Ages
- 40 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Patients over 40 years of age who are scheduled for open surgery with a diagnosis of colon cancer
Exclusion Criteria
- •Local anesthetic allergy
- •Patients scheduled for laparoscopic surgery
Outcomes
Primary Outcomes
urinary catheter withdrawal time
Time Frame: to be observed until the withdrawal of urinary catheter after the operation. it will be assessed up to 720 hours.
the time the urinary catheter was withdrawn after the operation
hospitalization time
Time Frame: from hospitalization for the operation to the day of discharge, it will be assessed up to 30 days.
The time from the day the patient was hospitalized before the operation to the day of discharge after the operation.
sPO2
Time Frame: perioperatively. "30 minutes" will be taken as the measurement period.
oxygene saturation
visual analog scale (VAS)
Time Frame: postoperative 24th hour.
A patient is asked to indicate his/her perceived pain intensity (most commonly) along a 5 cm horizontal line (between 0 and 5 points, 0 meaning 'no pain' and 5 meaning the worst) and this rating is then measured from the left edge (=Visual Analog Scale score).
drain removal time
Time Frame: to be observed until the withdrawal of abdominal drain after the operation. it will be assessed up to 720 hours.
the time the abdominal drain was withdrawn after the operation.
mobilization time
Time Frame: to be observed until the start of walking after the operation. it will be assessed up to 720 hours.
the time the patient was start to walk after the operation
blood pressure
Time Frame: perioperatively. "30 minutes" will be taken as the measurement period.
patients' mean arterial pressure levels
complications
Time Frame: to be observed for 30 days postoperatively.
all complications related with surgery or anesthesia
FiCO2
Time Frame: perioperatively. "30 minutes" will be taken as the measurement period.
inspiratory carbondioxide level
time to start oral intake
Time Frame: to be observed until the start of oral intake after the operation. it will be assessed up to 720 hours.
the time the patient start to consume orally after the operation
nasogastric withdrawal time
Time Frame: to be observed until the withdrawal of nasogastric tube after the operation. it will be assessed up to 720 hours.
the time the nasogastric tube was withdrawn after the operation.
Secondary Outcomes
No secondary outcomes reported
Investigators
Ayça Özcan
Associate Professor, MD
Ankara City Hospital Bilkent